Table I.
Summary of baseline features for 255 patients treated with primary RPLND for NSGCT.
| Feature | No. | % |
|---|---|---|
|
| ||
| Primary Tumor | ||
| Right | 133 | 52 |
| Left | 119 | 47 |
| Bilateral | 3 | 1 |
|
| ||
| Primary Histology | ||
| Mixed | 210 | 82.4 |
| Pure Embryonal | 41 | 16.0 |
| Pure Teratoma | 3 | 1.2 |
| Pure Malignant Transformation | 1 | 0.4 |
|
| ||
| Clinical Stage | ||
| IA | 26 | 10 |
| IB | 147 | 58 |
| IIA | 82 | 32 |
|
| ||
| Year of RPLND | ||
| 1999 | 26 | 10 |
| 2000 | 19 | 7 |
| 2001 | 31 | 12 |
| 2002 | 23 | 9 |
| 2003 | 27 | 11 |
| 2004 | 27 | 11 |
| 2005 | 16 | 6 |
| 2006 | 28 | 11 |
| 2007 | 22 | 9 |
| 2008 | 36 | 14 |
|
| ||
| pN Stage | ||
| N0 | 180 | 70 |
| N1 | 50 | 20 |
| N2 | 25 | 10 |
|
| ||
| RPLND Histology | ||
| Benign | 180 | 70 |
| Viable GCT (only) | 56 | 22 |
| Viable GCT and Teratoma | 10 | 4 |
| Teratoma (only) | 9 | 4 |